baber/WOPTO huggingface dataset:
Patent AU-2019260152-A1 (AU)
Title: Multifunctional high-frequency electric knife
Inventor: HU XIAO
IPC: A61B18/12
Filed: 2019-04-19
Abstract: The present invention belongs to the field of endoscopes and provides a multifunctional high-frequency electric knife, which comprises a processing portion, a sheath portion and an operating portion. The processing portion is provided with an electrode and a clip component; the electrode can be used for tissue cutting and liquid injection; the electrode is provided with a hollow tubular portion; the electrode can be pushed out or retracted relative to the far end of the sheath portion; the clip component is used for stopping bleeding of tissues, and the clip component can be pushed out or retracted relative to the far end of the sheath portion; the sheath portion is disposed at the near end of the processing portion and comprises a hollow pull rod and a spring tube; and the operating portion is located at the near end of the sheath portion and comprises a high-frequency joint connected to the electrode by means of a lead wire, a component that drives, by means of an operating line, the electrode to move, a member that drives the hollow pull rod to move, and a liquid inlet that allows liquid to flow to the hollow tubular portion of the electrode. The liquid can pass through the hollow tubular portion of the electrode to perform submucosal injection, such that the mucosal tissue is swelled, and a bleeding site can also be cleaned.
Patent AU-2019272011-A1 (AU)
Title: Prosthetic heart valve
Inventor: LEVI TAMIR
IPC: A61M29/02
Filed: 2019-11-28
Abstract: PROSTHETIC HEART VALVE An assembly for implanting a balloon-expandable prosthetic aortic heart valve (10) in a patient's body, the assembly comprising: a delivery apparatus comprising an elongated shaft having an inflatable balloon, and a prosthetic aortic heart valve (10) having a balloon-expandable frame (12) having a radially collapsed state and a radially expanded state, the frame (12) comprising: an inflow row of openings at an inflow end portion (174) of the frame (12), an outflow row of openings at an outflow end portion of the frame (12); and at least one intermediate row of openings between the inflow row of openings (174) and outflow row of openings; wherein the inflow row of openings (174) is formed by a circumferentially extending lower row of angled struts arranged end-to-end and a circumferentially extending first intermediate row of angled struts arranged end-to-end, the lower and first intermediate rows of angled struts interconnected by a plurality of substantially straight, axially extending struts, wherein the outflow row of openings is formed by a circumferentially extending upper row of angled struts arranged end-to-end and a circumferentially extending second intermediate row of angled struts arranged end-to-end, the upper and second intermediate rows of angled struts interconnected by a plurality of axially extending struts and a plurality of angularly spaced, axially extending commissure window frame portions, wherein each axially extending strut and each commissure window frame portion of the outflow row of openings extends from a location defined by the convergence of the lower ends of two angled struts of the upper row of angled struts to another location defined by the convergence of the upper ends of two angled struts of the second intermediate row of angled struts; and wherein adjacent angled struts of the frame (12) form an angle of at least 120, when the frame (12) is in the radially expanded state.
Patent AU-2019326617-A1 (AU)
Title: FASL immunomodulatory gene therapy compositions and methods for use
Inventor: NELLES DAVID A
IPC: C07K14/705
Filed: 2019-08-26
Abstract: Disclosed are compositions comprising a sequence encoding a non-self polypeptide of interest (POI), and a sequence encoding a non-cleavable FASL, wherein expression of the non-cleavable FASL in the presence of IL-6 or TNF-alpha eliminates MHC-mediated immunogenic peptides and helper T cells specific to the expression of the POI. Methods of making and methods of using compositions of the disclosure are also provided. For example, compositions of the disclosure may be used in the combined treatment of a disease or disorder in a subject and immune masking activity specific to the treatment. Exemplary disease or disorders of the disclosure include genetic and epigenetic diseases or disorders.
Patent AU-2019342447-A1 (AU)
Title: Combination therapy of acylthiourea compound and abiraterone
Inventor: ISHIBASHI YUKO
IPC: A61P19/00
Filed: 2019-09-18
Abstract: Provided is a cancer combination therapy which exhibits an excellent anti-tumor effect and has less side effects by using an acylthiourea compound which is a selective inhibitor of c-Met or a pharmaceutically acceptable salt thereof. Also, provided is an anti-tumor agent containing a compound represented by formula (I) below or a pharmaceutically acceptable salt thereof, the anti-tumor agent being characterized by being administered in combination with abiraterone or a derivative thereof.
Patent AU-2019350525-A1 (AU)
Title: Synthetic method for the preparation of a 3-[5-Amino-4-(3-Cyanobenzoyl)-Pyrazol compound
Inventor: MEISENBACH MARK
IPC: C07D231/38
Filed: 2019-09-26
Abstract: Provided is a process for preparing a compound, comprising the steps of a) Reacting a compound of Formula A (Formula A) with the compound 3 (3) to provide the compound 5 (5) or a salt or solvate thereof, wherein R is a linear or branched C1-C5 alkyl. Further provided is the compound 5 or a salt or solvate thereof. (5) The use of these compounds in the synthesis of 3-[5-Amino-4-(3- Cyanobenzoyl)-Pyrazol-1-yl]-N-Cyclopropyl-4-Methylbenzamide is also provided.
Patent AU-2019352482-A1 (AU)
Title: PDGF receptor antibody and use thereof
Inventor: KIM SOOHYUN
IPC: A61K45/06
Filed: 2019-10-07
Abstract: The present invention relates to: a PDGF receptor antibody; an antibody-drug conjugate in which a chemotherapeutic agent is conjugated to the PDGF receptor antibody; and a use for preventing or treating angiogenic diseases by using same.
Patent AU-2019370555-A1 (AU)
Title: Biocompatible nanomagnetic discs and methods of use thereof
Inventor: POTTATHIL RAVEENDRAN
IPC: A61K33/24
Filed: 2019-11-01
Abstract: Provided herein are compositions including biocompatible magnetizeable nanoparticles. The nanoparticles have a diameter (average diameter) from about 10 to about 300 nanometers and are biocompatible and magnetic. The nanoparticles may be a disc formed from iron oxide. The disc may be comjugated to a target-binding moiety capable of binding a target. The target may be cancer cells, pathogens, fat cells, or atherosclerotic plaques.
Patent AU-2019370856-A1 (AU)
Title: Device for discharging and returning fluids
Inventor: SCHULZ-HILDEBRANDT LASSE
IPC: B67D7/04
Filed: 2019-10-28
Abstract: The invention relates to a device for discharging a first fluid and for returning a second fluid, comprising a main channel (13) for discharging the first fluid and a return channel (14) for returning the second fluid. According to the invention, a test channel (15) is provided which connects the main channel (13) to the return channel (14), the main channel (13) having a narrowing (16) and the test channel (15) issuing into the main channel (13) in the region of the narrowing (16). The device further has a sensor (17) which is designed to determine a pressure in the test channel (15). The invention further relates to an outflow tube, a delivery nozzle and a delivery pump having a device according to the invention. With the aid of the invention, active return of the second fluid can be shut off in a simple and safe manner.
Patent AU-2019390486-A1 (AU)
Title: Rust resistance gene
Inventor: ZHANG JIANPING
IPC: C12Q1/68
Filed: 2019-04-12
Abstract: The present invention relates to a plant which has integrated into its genome an exogenous polynucleotide encoding a polypeptide which confers resistance to at least one strain of
Patent AU-2019401314-A1 (AU)
Title: Compositions for DRG-specific reduction of transgene expression
Inventor: HORDEAUX JULIETTE
IPC: A61K48/00
Filed: 2019-12-20
Abstract: Provided herein is a recombinant AAV (rAAV) comprising an AAV capsid and a vector genome packaged therein, wherein the vector genome comprises an AAV 5 ' inverted terminal repeat (ITR), an engineered nucleic acid sequence encoding a gene product for expression in target cells, and miRNA target sequences which selectively repress expression in dorsal root ganglion (DRG) cells. Also provided is a pharmaceutical composition comprising a rAAV as described herein in a formulation buffer, and a method of treating a human subject with CNS -targeted gene therapy while selectively preventing expression in DRG cells.
Patent WO-2020142804-A1 (WO)
Title: Foot actuated vehicle control surfaces, operation and control strategy
Inventor: BROADBENT JULIAN
IPC: B60T7/06
Filed: 2020-01-08
Abstract: A foot actuated vehicle control system comprising a pedal including at least one load/pressure sensing device. The pedal being integrated into or mounted on the vehicle floor structure and responsive to user applied force, with minimal displacement of said sensing device, to generate control signals operative to control motive and/or braking function of the vehicle, in use.
Patent WO-2020160592-A1 (WO)
Inventor: MATTERS BRENTON GEORGE
IPC: B65G53/50
Filed: 2020-02-07
Abstract: L'invention concerne un système de déchargement d'un matériau particulaire à partir d'un conteneur (système de déchargement). Selon un aspect, le système de déchargement comprend un système de décharge pour transporter le matériau d'un ou de plusieurs compartiments vers une sortie de conteneur et un système de commande pour commander le fonctionnement du système de déchargement. Le système de décharge comprend une soupape de décharge positionnée au niveau d'une sortie de matériau pour chaque compartiment pour commander la décharge du matériau du compartiment dans une ligne de décharge. Le système de déchargement comprend une ligne de suralimentation s'étendant d'une ligne d'alimentation en pression à la ligne de décharge et comprenant une soupape de surpression réglable. Le système de commande comprend au moins un capteur de pression pour la ligne de décharge, le système de commande, lors de l'utilisation, surveille la pression de la ligne de décharge en continu et commande la soupape de suralimentation en réponse par l'intermédiaire d'une boucle de rétroaction, ajustant la position de la soupape de suralimentation en réponse à la pression de la ligne de décharge pour maintenir un écoulement de matériau.
Patent WO-2021035275-A1 (WO)
Title: An interdental cleaning device
Inventor: WEBBER JAMIE
IPC: A46B15/00
Filed: 2020-08-24
Abstract: An interdental cleaning device includes a handle. A cleaning head assembly is mounted on the handle. The cleaning head assembly includes a head that is mounted on the handle, the head defining a cavity. An interdental cleaning member is mounted on the head to extend into the cavity, the interdental cleaning member including an interdental cleaning element. A plunger is mounted on the head, the plunger being reciprocally displaceable relative to the head between an operative position in which the plunger is at least partially retracted into the cavity and an inoperative position in which the plunger extends from the cavity. A spring mechanism is interposed between the plunger and the head so that the movement of the plunger into the operative position is against a bias of the spring mechanism. The plunger defines a longitudinally extending passage that is dimensioned to accommodate the cleaning element. The interdental cleaning member is positioned so that the interdental cleaning element extends from a distal opening of the longitudinal passage when the plunger is in the operative position and is positioned within the plunger when the plunger is in the inoperative position.
Patent AU-2020200576-A1 (AU)
Title: Biodegradable lipids for delivery of nucleic acids
Inventor: DEROSA FRANK
IPC: A61K48/00
Filed: 2020-01-28
Abstract: The present invention provides, in part, a biodegradable compound of formula I, and sub formulas thereof: Formula (I) or a pharmaceutically acceptable salt thereof, where each X independently is 0 or S, each Y independently is 0 or S, and each R, independently is defined herein; and a liposome composition comprising the cationic lipid of formula I or a sub-formula thereof, and methods of delivering agents, such as nucleic acids including mRNA, in vivo, by administering to a subject the liposome comprising the cationic lipid of formula I or a sub formula thereof, where the agent is encapsulated within the liposome.
Patent AU-2020203089-A1 (AU)
Title: Anti-unmanned aerial vehicle defense apparatus, protective device for fighting an unmanned aircraft, and method for operating a protective device
Inventor: STARK ROBERT
IPC: F41H13/00
Filed: 2020-05-11
Abstract: Abstract A defense device for combating an unmanned aircraft, comprising - a communications device (2) that is designed for receiving communica tions information transmitted by at least one external signal source (22, 26), 5 - an emitting device (3) that is designed for producing and emitting a high-energy electromagnetic pulse in the event of triggering of the emitting device (3), and - a control device (4) that is designed to trigger the emission of the high energy electromagnetic pulse depending on communications infor 10 mation received by the communications device (2). Figure 4 3056564v1 0) C14 -------- ---- - 3056564ll
Patent AU-2020204132-A1 (AU)
Title: System and method for monitoring buildings including facades
Inventor: SMITHSON PETER
IPC: G06F17/40
Filed: 2020-06-19
Abstract: A computer-implemented system including a plurality of environmental parameter 
sensors affixed to, or associated with, a building including a plurality of sensors affixed to 
components of the building facade and configured to continuously monitor one or more 
environmental parameters; the plurality of sensors in data communication with a data 
recordal device configured to capture sensor data generated by the plurality of sensors; 
and a computing device in communication with the data recordal device including one or 
more processors that receive and process the sensor data captured by the data recordal 
device to thereby assess the performance of the building facade.
1/5 
0 
0 
L
.............. ...............  
....-...
Patent AU-2020224581-A1 (AU)
Title: Estimating object properties using visual image data
Inventor: MUSK JAMES ANTHONY
IPC: G06K9/00
Filed: 2020-02-07
Abstract: A system is comprised of one or more processors coupled to memory. The one or more processors are configured to receive image data based on an image captured using a camera of a vehicle and to utilize the image data as a basis of an input to a trained machine learning model to at least in part identify a distance of an object from the vehicle. The trained machine learning model has been trained using a training image and a correlated output of an emitting distance sensor.
Patent AU-2020233693-A1 (AU)
Title: Compacted hemostatic cellulosic aggregates
Inventor: WANG YI-LAN
IPC: A61L15/24
Filed: 2020-09-16
Abstract: The present invention is directed to a hemostatic material comprising a compacted, 
hemostatic aggregates of cellulosic fibers. In some aspects, the hemostatic material further 
includes additives, such as carboxymethyl cellulose (CMC) or other polysaccharides, calcium 
salts, anti-infective agents, hemostasis promoting agents, gelatin, collagen, or combinations 
thereof. In another aspect, the present invention is directed to a method of making the 
hemostatic materials described above by compacting a cellulosic-based material into 
hemostatic aggregates. In another aspect, the present invention is directed to a method of 
treating a wound by applying hemostatic materials described above onto and/or into the 
wound of a patient.
Patent AU-2020239716-A1 (AU)
Title: Hard-shell luggage systems
Inventor: KOREY STEPHANIE
IPC: A45C5/00
Filed: 2020-09-24
Abstract: JRS 
ABSTRACT 
A hard-shell luggage system (1) comprising: a front hard-shell housing portion (3A); a rear 
hard-shell housing portion (3B) hinged together (3C) with the front hard-shell housing portion 
to form a hard-shell housing assembly; a laundry bag subsystem (36) coupled to a bottom 
surface of the rear hard-shell housing portion, the laundry bag subsystem being contained 
within the hard-shell luggage system and including: a laundry bag component (36A) defining 
an internal volume for storing soiled clothes, the internal volume being accessible from within 
the hard-shell luggage system and capable of being closed by a fastening mechanism inside 
the hard-shell luggage system; and a laundry bag storage pouch (36C) for containing the 
laundry bag component when empty of soiled clothes and folded up; and a compression pad 
subsystem (32A) installed in the rear hard-shell housing portion and including a compression
pad structure coupled to the interior volume of the rear hard-shell housing portion using a set 
of compression straps (36C, 36D); wherein the laundry bag subsystem is configured to 
interface with the compression pad subsystem to compress at least one of: (i) the laundry bag 
component and clothes stored therein toward the rear hard-shell housing portion, or (ii) 
garments outside the laundry bag component toward the rear hard-shell housing portion.
WO 2017/079707 PCT/US2016/060738 
8/103 
0 
co 
co0 
(0......... ................................................. C 
. . . . . . . . . . . . . . .... .. ......... .......  
(0.  
co 
I0- -~ -I - - - -co; 
M 
....... 2L 
........ .  
Co (0c: 
< <
Patent AU-2020259142-A1 (AU)
Title: Novel formulations comprising melflufen
Inventor: LEHMANN FREDRIK
IPC: A61K47/10
Filed: 2020-04-17
Abstract: The invention provides a pharmaceutical formulation comprising (or consisting essentially of) the following components: i) melflufen, or a salt thereof; ii) propylene glycol; iii) optionally one or more physiologically acceptable aqueous solvent(s); and iv) optionally one or more additional therapeutic agent(s); or a pharmaceutical formulation comprising (or consisting essentially of) the following components: i) melflufen, or a salt thereof; ii) polyethylene glycol; iii) optionally one or more physiologically acceptable aqueous solvent(s); and iv) optionally one or more additional therapeutic agent(s). The invention also provides methods for preparing the pharmaceutical formulations of the invention, kits and uses of the pharmaceutical formulations of the invention.
Patent AU-2020267199-A1 (AU)
Title: Valsalva mask
Inventor: Melissa Catherine Bornholdt
IPC: A61M16/00
Filed: 2020-11-11
Abstract: An interface for positive pressure therapy includes a mask assembly and a headgear 
assembly. The mask assembly comprises a mask seal that is adapted to underlie the nose.  
5 The mask seal extends up the lateral sides of the nose. The mask seal has a primary seal 
below the nose and a secondary seal alongside the nose.  
-58-
Patent AU-2020267259-A1 (AU)
Title: Reduced oxygen carriers and their use for the treatment of carboxyhemoglobinemia
Inventor: ROSE JASON JOSEPH
IPC: A61K38/42
Filed: 2020-11-12
Abstract: In vitro and in vivo methods of removing carbon monoxide from hemoglobin in blood or 
animal tissue are described. Methods of treating carboxyhemoglobinemia (carbon monoxide 
poisoning) in a subject are also described. The methods include administering natural or artificial 
oxygen carriers that are in their reduced form. Methods of producing a reduced oxygen carrier are 
further described. Methods of treating cyanide poisoning or hydrogen sulfide poisoning with 
oxygen carriers are also described.
Patent AU-2020271227-A1 (AU)
Title: Transmon qubits with trenched capacitor structures
Inventor: ADIGA VIVEKANANDA
IPC: H01L27/18
Filed: 2020-04-06
Abstract: A qubit includes a substrate, and a first capacitor structure having a lower portion formed on a surface of the substrate and at least one first raised portion extending above the surface of the substrate. The qubit further includes a second capacitor structure having a lower portion formed on the surface of the substrate and at least one second raised portion extending above the surface of the substrate. The first capacitor structure and the second capacitor structure are formed of a superconducting material. The qubit further includes a junction between the first capacitor structure and the second capacitor structure. The junction is disposed at a predetermined distance from the surface of the substrate and has a first end in contact with the first raised portion and a second end in contact with the second raised portion.
Patent AU-2020271841-A1 (AU)
Title: System and method for customer journey event representation learning and outcome prediction using neural sequence models
Inventor: NEGI SAPNA
IPC: G06Q30/00
Filed: 2020-04-09
Abstract: A system and method are presented for customer journey event representation learning and outcome prediction using neural sequence models. A plurality of events are input into a module where each event has a schema comprising characteristics of the events and their modalities (web clicks, calls, emails, chats, etc.). The events of different modalities can be captured using different schemas and therefore embodiments described herein are schema-agnostic. Each event is represented as a vector of some number of numbers by the module with a plurality of vectors being generated in total for each customer visit. The vectors are then used in sequence learning to predict real-time next best actions or outcome probabilities in a customer journey using machine learning algorithms such as recurrent neural networks.
Patent AU-2020286015-A1 (AU)
Title: Capsule and plug for a concentrated refill capsule
Inventor: DEN BOER SEBASTIAAN WILHELMUS JOSEPHUS
IPC: B05B11/00
Filed: 2020-05-22
Abstract: A plug for use in a cap assembly of a refill capsule is disclosed. The plug (300) generally comprises a hollow tubular body (302) with an open proximal end that is surrounded by a first rim (304) that provides a proximal abutment surface for bearing against a frangible sealing component of a cap assembly. A tubular skirt wall (306) is arranged coaxially with respect to the tubular body, and extends around the skirt wall (306) to form a plug recess (308) between the skirt wall (306) and the tubular body (302). The skirt wall (306) extends from a skirt distal end at which the skirt wall (306) is connected to the tubular body (302), to a free proximal end. The free proximal end of the skirt comprises an outwardly extending flange (310) comprising a distal facing abutment surface (312) for abutting a rim (406) of a refillable vessel (400).
Patent AU-2020289521-A1 (AU)
Title: Method, system and apparatus for dynamic task sequencing
Inventor: SAKHDARI BIJAN
IPC: B25J9/16
Filed: 2020-04-13
Abstract: A method in a navigational controller includes: obtaining (i) a plurality of task fragments identifying respective sets of sub-regions in a facility, and (ii) an identifier of a task to be performed by a mobile automation apparatus at each of the sets of sub-regions; selecting an active one of the task fragments according to a sequence specifying an order of execution of the task fragments; generating a path including (i) a taxi portion from a current position of the mobile automation apparatus to the sub-regions identified by the active task fragment, and (ii) an execution portion traversing the sub-regions identified by the active task fragment; during travel along the taxi portion, determining, based on a current pose of the mobile automation apparatus, whether to initiate execution of another task fragment; and when the determination is affirmative, updating the sequence to mark the other task fragment as the active task fragment.